119TiP An observational study to assess the effectiveness and safety of cemiplimab in patients with advanced non-small cell lung cancer (NSCLC) in routine clinical practice within Europe (CEMI-LUNG). (December 2022) - Gessner, C.; Griesinger, F.; Shah, R.; Talbot, T.; Venkateshan, S.; Vadanahalli Shankar, A.K.; Seluzhytsky, A.; Marsden, D.M.